Clinical Trial Update: Overcoming Membrane Transporters to Improve CNS Drug Delivery - Improving Brain Antioxidants After Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating strategies to bypass brain membrane transporters to improve delivery of brain antioxidants after traumatic brain injury. Res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Not disclosed

Snippet

Sponsor: University of Pittsburgh | Conditions: Pediatric Traumatic Brain Injury | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-08-15